CDK4 and cancer: By binding to retinoblastoma (Rb) protein and cyclin-dependent kinase 4 (CDK4), Gankyrin facilitates the phosphorylation and degradation of Rb and activates the E2F family of transcription factors, thus promoting tumorigenicity and cancer cell proliferation5, 8, 9.